ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

MRI Detects Cancer In The Opposite Breast Of Newly Diagnosed Women, Study Finds

March 30, 2007

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

Clinical Trials Approved By NCI

November 26, 2010

Assumption, Not Facts Form Base For Regulation Of Carcinogens, One Regulatory Coucil consultant Says; request for Study By NSA Denied

June 8, 1979